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Webappendix for: Falciparum malaria is a major risk factor for bacteraemia in 
Kenyan children; evidence from the malaria-protective effect of sickle cell trait. 
Methods of the case-control studies 
1. Matched case-control study 
The objective of this study was to describe the major biological predisposing factors for the invasive 
bacterial disease in Kenyan children, including HIV, sickle cell disease, malaria and malnutrition. We 
selected hospitalisation with bacteraemia as a case-definition for invasive bacterial disease because it 
was specific and widely recognised, and because we were planning simultaneously to do an inpatient 
study of the aetiology of bacteraemia among children in Kilifi (1). Both studies were reviewed and 
approved by the KEMRI National Ethical Review Committee within the same protocol; each study had 
separate but overlapping study populations and had separate consent forms. 
Case definition 
Children were eligible for recruitment in the case-control study if they were admitted to Kilifi District 
Hospital between 16th September 1999 and 31st of July 2002. During this period, under the provisions 
of the bacteraemia aetiology study, all children admitted to the paediatric ward were investigated with 
blood cultures on admission except those with elective surgery or minor trauma requiring overnight 
observation. On admission, each child's skin was cleaned with 70 percent ethanol and allowed to dry 
before blood was drawn for culture and antimicrobial testing. Blood was inoculated into a culture bottle 
(BACTEC Peds Plus, Becton Dickinson) after the needle had been changed and the top had been 
cleaned with 70 percent ethanol and allowed to dry. If the blood cultures taken on admission yielded a 
pathogenic bacterial isolate, the microbiology laboratory informed the clinical research staff who 
adjusted treatment where necessary and approached the family of the patient to ask for consent for the 
participation of their child in the case-control study. All bacteria cultured from the blood were 
considered pathogenic except those commonly found as contaminants, including coagulase-negative 
staphylococci, micrococcus species, bacillus species and virdans streptococci. 
Exclusion criteria: 
 
a. Age <3 months. Young infants have a different pattern of pathogens causing invasive bacterial 
disease and are likely to have a different set of risk factors. 
b. Age >13 years. This was the upper limit for admission to the paediatric ward. 
c. Discharged from hospital within the last 14 days. The objective of the study was to define the 
risks of community-acquired invasive bacterial disease not hospital-acquired infection. 
d. Death in hospital between admission and the isolation of a pathogenic bacterium. 
Ascertainment of the full list of exposures would be incomplete if the child could not be 
examined by the research team. 
e. Absconding from the hospital between admission and the isolation and identification of a 
pathogenic bacterium. 
Control definition 
Healthy community controls were individually matched to cases on age, sex, geographic location and 
time. Wherever possible, two controls were recruited for each case identified. At the point a case was 
recruited, a fieldworker was notified of the requirement to recruit two control participants. The 
fieldworker obtained the directions to the child’s home by interviewing the relatives caring for the 
child in hospital and then travelled to the house. There, he spun a pencil on the ground to provide an 
random direction in which to seek out a location-matched control. Continuing always in this direction, 
he asked that each house in turn whether the house contained a resident child who fitted the matching 
criteria of sex and age; the control child should be the same sex as the case and should fall in the same 
age stratum. The predefined age strata were 2-11, 12-23, 24-59 and ≥60 months. Having found a 
matched control, the fieldworker continued walking in the same direction until he was able to recruit a 
second control. The fieldwork was required to recruit two controls within 14 days of the identification 
of the case because several of the exposure variables were strongly associated with season. 
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Exclusion criteria: 
a. Aged <2 months.  
b. Aged >13 years.  
c. Discharge from hospital within the last 14 days.  
d. Child sick on the day of recruitment. 
Exposure ascertainment 
At the first contact between the research staff and a case, in hospital, or a control at his/her own home, 
the study was explained to the parents/guardians of the child and written consent was obtained for 
participation in the study. Exposure variables obtained by questionnaire were ascertained by 
interviewing the parents/guardians of cases on the ward and of controls in their own homes. Risk 
factors that required clinical examination were ascertained at the hospital; the parents of healthy 
controls were given an appointment to attend the hospital and the child was examined by the study 
doctor and underwent a blood test. The questionnaire variables included age, sex, current health status, 
location of residence, date of recruitment, number of years of education of father and mother, mother's 
ethnic group and father’s ethnic group. At clinical examination the child was weighed and measured 
(height or length as appropriate) using scales and rulers that were calibrated weekly. A mid upper arm 
circumference was taken using a tape measure designed for the purpose. The study doctor examined 
the child for skin and hair changes of malnutrition, pedal oedema, a BCG scar and splenomegaly. 
Blood was taken for haemoglobin concentration, red and white blood cell counts, a malaria blood film, 
HRP2 assay, the presence of leucocyte haemozoin pigment and determination of sickle cell status. 
Blood cultures were not obtained from controls. 
Laboratory methods 
Blood was cultured using a BACTEC 9050 automated instrument (Becton Dickinson, UK). Bottles that 
signalled positive were sub-cultured onto blood agar, chocolate agar and McConkey agar. Bottles were 
considered negative if they did not signal within 5 days, and were discarded. Isolates growing on these 
sub-cultures were identified using conventional microbiological techniques and biochemical tests (API, 
Biomerieux). Quality assurance was provided by the UK National External Quality Assessment 
Service (www.ukneqas.org.uk). Isolates of Streptococcus pneumoniae were serotyped by Quelling 
reaction and of Haemophilus influenzae were serotyped by latex agglutination. 
Antibodies to HIV were tested by enzyme-linked immunosorbent assay (ELISA) (Vironostika, 
Biomerieux) and dipstick (Determine, Abbott Laboratories). Positive samples from children under 18 
months of age and samples with discordant results were assayed by PCR for proviral DNA. 
Haemoglobin, red blood cell count and white blood cell count were assayed by Coulter counter. Blood 
was examined for malaria parasites by microscopy of Giemsa-stained thick and thin films. Parasite 
densities were calculated as parasite counts per 500 red blood cells (or per 100 white blood cells) 
multiplied by the relevant blood cell concentration measured by Coulter counter. Leucocyte haemozoin 
pigment, a marker of recent malaria infection, was detected by slide microscopy (2). Plasma levels of 
the malaria antigen histidine rich protein 2 (HRP2) were measured by sandwich ELISA against a 
known concentration standard (3); HRP2 is secreted by red blood cells infected by P. falciparum and is 
detectable in the plasma of adult patients with uncomplicated malaria for ≥2 weeks (4). HbS phenotype 
was determined by citrate-agar electrophoresis using standard methods. 
Sample size 
The sample size was based on the estimated prevalences of the four major exposure variables. With 
alpha of 0.05, an assumed correlation between case-control pairs of 0.2 and a control/case ratio of 2, a 
study of 300 cases provided adequate power to detect a useful range of odds ratios across the 
prevalences of these variables. 
Risk Estimated Odds Ratio 
Factor Prevalence 1.5 2.0 2.5 3.0 
HIV 0.03 0.178 0.453 0.724 0.895 
Malnutrition 0.07 0.321 0.764 0.960 0.996 
Malaria pigment 0.1 0.411 0.873 0.990 1.000 
Parasitaemia 0.3 0.709 0.992 1.000 1.000 
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The table shows the power of the study for exposure variables of different prevalence at a range of 
potential odds ratios varying between 1.5-3.0. Power calculations were derived from equations in 
Dupont (5) 
Statistical analysis 
Data were assembled in case-control sets consisting of either pairs (where only one control was 
recruited) or triplets (where two controls per case were recruited). For each exposure variable the 
number of concordant and discordant pairs was calculated and tabulated. Odds ratios, 95% confidence 
limits and P values were calculated using classical methods (6). For the multivariable analysis, we 
performed hierarchical modelling using logistic regression, conditional on the case-control sets. For 
two key exposures, malaria and malnutrition, we had a variety of different measures of the exposure, 
and we wished to select the measure which best represented the exposure variable before controlling 
for confounding by other variables. We first repeated the univariate analysis using conditional logistic 
regression. Next, we developed separate intermediate models of these two sets of variables using 
backward stepwise regression. Each variable was tested with a likelihood ratio test and variables that 
were significant at P<0.1 were retained in the intermediate model. At the second stage of modelling, 
we included all variables with P <0.1 in the univariate analysis plus those retained in the intermediate 
models. We developed the final model using backward stepwise conditional logistic regression. 
Variables were retained in the final model if they had a likelihood ratio test P <0.05. Finally, we 
examined the final model variables in two subsets of the cases-control sets, those which included a case 
of pneumococcal bacteraemia and those which included a case of non-Typhoidal salmonella. 
2. Longitudinal case-control study 
This study was conceived and designed at the end of the study period in order to examine, specifically, 
the effect of declining malaria incidence on the protection against bacteraemia afforded to children 
with sickle cell trait. The opportunity to conduct a retrospective, longitudinal, case-control study arose 
out of two existing longitudinal studies: (1) a longitudinal clinical surveillance study of severe diseases 
of children, including bacteraemia, at Kilifi District Hospital and (2) a genetic cohort study of 
susceptibility to malaria conducted in the area of the Kilifi Health and Demographic Surveillance 
System (KHDSS), which surrounds Kilifi District Hospital (7). 
Case definition 
We defined a case as any child, aged <14 years, admitted to Kilifi District Hospital between 1st January 
1999 and 31st of December 2007 in whom a blood culture yielded a pathogenic bacterial isolate. 
Throughout this period children were investigated in a consistent manner with a blood culture on 
admission, as described in the matched case-control study. A child could only become a case if the 
pathogenic isolate was cultured from a blood sample that had been taken on admission; hospital-
acquired infections were not included. The venesection method was constant throughout the period and 
is described under the section on the matched case-control study. All isolates of bacteria cultured from 
blood were considered pathogenic unless they were of species defined to be contaminants (listed 
above). As there was an overlap between the study periods for the matched case-control study and the 
longitudinal case-control study, some cases were included in both studies. However, in the longitudinal 
case-control study the number of exposures ascertained was much smaller than in the matched study 
and these were readily available within the clinical surveillance study database. Therefore it was not 
necessary to exclude children because they died between admission to hospital and the isolation of a 
pathogen from blood. 
Exclusion criteria 
A. Age >13 years 
B. Not resident within the KHDSS area 
C. Did not consent to the Kilifi District Hospital clinical surveillance study. 
D.  Already recruited to the study within the last 6 months. 
Control definition 
For this study we used as controls a cohort of children who had been recruited into a study of genetic 
susceptibility to malaria and other infectious diseases. The Kilifi Genetic Birth Cohort Study (KGBCS) 
began recruiting children on 1 January 2006 and we included in this case-control analysis all children 
recruited up until 23 June 2009. The objective of the cohort recruitment procedure was to approach 
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every child aged 3 to 11 months who was resident in the Kilifi Health and Demographic Surveillance 
Study area. The fieldworkers recruiting participants in this study obtained lists of residents, including 
newly born children, from the KHDSS and visited the family at home to explain the study and to invite 
the parents/guardians to consent to the participation of their child. Because of the nature of the study, 
looking at genetic susceptibility traits, the research team developed a comprehensive plan of 
community communication before embarking on the study. The results of the major genotype under 
scrutiny, sickle cell disease, were communicated back to the parents/guardians. 
Exposure ascertainment 
In this study only four exposure variable were analysed; sex, ethnic group, geographic location of 
residence, and sickle cell status. Among cases, sex, ethnic group and geographic location were 
recorded in the computer-based clinical records of the Kilifi clinical surveillance study. We examined 
sickle-cell status by assaying stored whole blood samples that had been frozen at the point of admission 
to hospital. Among controls, sex, ethnic group and geographical location were already known at the 
point of recruitment, from the listing of residents in the in the KHDSS. Sickle cell status was 
ascertained from capillary blood samples obtained at home visits shortly after recruitment to the cohort 
study, and analysed for sickle cell status within 7 days of collection. 
Laboratory methods 
Blood cultures were processed and analysed in a consistent manner throughout the whole of the study 
period; the methods are described in detail under the matched case-control study. 
DNA from cases was extracted, retrospectively, from frozen blood samples, collected on admission, 
using Qiagen DNA blood mini kits (Qiagen, Crawley, UK) and typed for HbS by PCR (8). For 
controls, capillary blood samples were phenotyped for HbS by HPLC (Variant Analyzer, BioRad, 
Hercules, CA) using the β-thalassaemia short program. 
Statistical analysis 
The sample size in this study was determined by the number of cases and controls available within the 
existing Kilifi clinical surveillance records and the KGBCS rather than by theoretical consideration or 
calculation. We used logistic regression to estimate the odds ratio and 95% confidence limits for sickle 
cell trait among cases and controls, taking account of potential confounders sex, ethnic group, and 
geographical residence within the Kilifi Health and Demographic Surveillance Study area. To control 
for geographic residence we divided the area into five strata. In order to observe the change in the odds 
ratio over time we conducted a separate analysis for each year of the nine-year study period; all of the 
cases identified in one year were compared against all of the controls within the KGBCS. This 
approach produced nine odds ratios describing the trend in the association between sickle cell trait and 
bacteraemia during the period of declining malaria incidence. 
Two limitations of this method are noteworthy. Firstly, we were unable to control for age in this 
analysis; although the cases varied in age from newborns to 13-year-olds, all of the controls were 
infants. Whilst we know that the prevalence of sickle cell disease declines sharply in early childhood, 
the prevalence of sickle cell trait does not increase appreciably through early childhood. It is very 
unlikely therefore that this led to a perceptible degree of confounding. Secondly, we were unable to 
control for time; although the cases were recruited evenly throughout a nine-year period, the controls 
were all recruited within a three-year period at the end of the study. It is possible, that the decline in the 
burden of malaria in this area during the study period could have led to a decline in the gene frequency 
of the βs gene and this could have contributed to the change in the odds ratio of sickle cell trait and 
bacteraemia. The potential for such confounding can be seen and evaluated in the prevalence of sickle 
cell trait among the controls in the matched case-control study and the longitudinal case-control study. 
A small change is unlikely to lead to confounding. Furthermore, a comparison of the odds ratios 
obtained at the end of the longitudinal case control study with those obtained in the matched case-
control study will illustrate the potential for confounding by time, because in each instance the controls 
were recruited contemporaneously with the cases. 
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Supplementary Tables and Figures 
Table S1. Pathogenic bacteria isolated from blood cultures among children admitted to Kilifi District 
Hospital between 1999 and 2002 who were recruited as cases in the matched case-control study. 
 
Organism Frequency Percent 
Acinetobacter sp 18 6.16 
Pantoea agglomerans 2 0.68 
Escherichia coli 19 6.51 
Enterobacter sp 2 0.68 
Haemophilus influenzae 37 12.7 
Klebsiella pneumoniae 3 1.03 
Neisseria meningitidis 1 0.34 
Pseudomonas aeruginosa 2 0.68 
Pseudomonas oryzihabitans 1 0.34 
Pseudomonas stutzeri 2 0.68 
Salmonella sp (non-Typhi) 61 20.9 
Staphylococcus aureus 15 5.14 
Shigella flexneri 2 0.68 
haemolytic Streptococcus Group A 5 1.71 
haemolytic Streptococcus Group B 1 0.34 
Enterococcus spp 7 2.40 
haemolytic Streptococcus Group G 2 0.68 
Streptococcus pneumoniae 111 38.0 
Salmonella Typhi 1 0.34 
Total 292 100 
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Table S2. Numbers of cases and control pairs, concordant and discordant, in the classical analysis of 
the matched case-control study together with classical univariate odds ratios. 
 
  number of exposed controls  No. No. of     
exposure variable case 
CC 
pairs  CC triplets  of discordant Analytic results 
  status 0 1   0 1 2   pairs pairs OR 
lower 
CI 
upper 
CI p 
unexp 87 1  138 0 0  383 20 15 2.3 97.91 0.0007 HbSS (v HbAA) 
exp 7 0  6 0 0        
unexp 35 9  138 52 7  483 111 0.47 0.29 0.77 0.003 HbAS (v HbAA) 
exp 3 2  13 7 0        
unexp 39 2  174 6 0  527 132 14.56 7.10 29.84 <0.0005 HIV infection 
exp 14 0  54 2 0        
unexp 33 14  78 62 33  528 219 0.53 0.38 0.76 <0.0005 P. falciparum>0 
exp 5 4  25 22 16        
unexp 51 4  181 34 3  528 78 0.75 0.43 1.31 0.48 P. falciparum 
>10,000/mcl exp 1 0  15 3 0        
unexp 54 1  215 8 0  528 36 2.89 1.25 6.70 0.03 P. falciparum 
>50,000/mcl exp 1 0  13 0 0        
unexp 46 0  169 23 2  524 111 3.28 2.02 5.31 <0.0005 Haemozoin pigment 
exp 9 1  35 5 0        
unexp 79 6  57 4 1  254 52 3.03 1.52 6.07 0.002 HRP2>0ng/ml 
exp 11 2  13 3 0        
unexp 90 1  74 1 0  251 12 4.8 0.99 23.24 0.14 HRP2>20ng/ml 
exp 4 0  3 0 0        
unexp 33 4  113 50 6  528 194 2.01 1.43 2.81 <0.0005 palpable spleen 
exp 17 2  47 17 3        
unexp 16 21  24 75 44  528 257 0.39 0.28 0.54 <0.0005 weight-for-age  
z-score ≥-1.8 exp 5 14  15 38 40        
unexp 13 15  38 59 33  528 241 0.71 0.52 0.96 0.043 height-for-age 
 z-score≥-1.6 exp 7 21  24 46 36        
unexp 15 25  36 66 42  528 252 0.43 0.31 0.59 <0.0005 weight-for-height  
z-score≥-1.1 exp 6 10  12 47 33        
unexp 44 2  180 12 1  528 106 5.56 3.15 9.81 <0.0005 skin or hair changes of 
malnutrition exp 9 1  38 5 0        
unexp 55 0  212 0 0  530 51 - - -  pedal oedema 
exp 3 0  24 0 0        
unexp 1 4  1 10 34  525 155 0.94 0.65 1.36 1 BCG scar 
exp 12 40  6 49 134        
unexp 46 3  210 10 1  524 45 2.03 1.01 4.08 0.12 maternal ethnic group 
not Mijikenda exp 7 0  11 1 1        
unexp 47 3  212 11 1  524 36 1.29 0.61 2.7 1 paternal ethnic group 
not Mijikenda exp 5 1  6 3 1        
unexp 15 13  46 52 25  514 228 0.99 0.73 1.34 1 maternal education  
≥1 year exp 14 12  25 49 33        
unexp 15 18  11 31 24  382 166 0.7 0.49 1 0.09 paternal education  
≥7 years 
  
exp 11 36   9 40 36               
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Table S3. Subgroup analysis of the matched case-control study to examine specific risk factors 
for pneumococcal bacteraemia and non-Typhi Salmonella bacteraemia. 
 
 
All bacteraemia cases 
Pneumococcal 
bacteraemia 
non-Typhi Salmonella 
bacteraemia 
Exposure Variable OR 95%CI OR 95%CI OR 95%CI 
HbSS 22.9 2.47, 211 - - 9.35 0.57, 153 
HbAS 0.36 0.20, 0.65 0.35 0.13, 0.91 0.21 0.05, 0.97 
HIV 9.03 3.59, 22.7 14.9 3.28, 67.7 11.3 1.32, 96.4 
Leucocyte haemozoin pigment 3.52 1.92, 6.47 1.51 0.59, 3.86 16.5 3.44, 79.3 
Mid-upper arm circumference/cm 0.57 0.49, 0.66 0.67 0.53, 0.84 0.43 0.27, 0.68 
 
Odds ratios and 95% confidence intervals were estimated using conditional logistic regression with the 
subset of cases with S. pneumoniae bacteraemia and non-Typhi Salmonella bacteraemia and their 
matched controls. The S. pneumoniae analysis contained 104 cases and 202 controls; the Salmonella 
analysis contained 60 and 109 controls. Exposure variables selected were those that were significant in 
the final adjusted model of the full dataset (see Table 1). The odds ratio for HbSS is missing in the 
pneumococcal sub-group model because none of the cases of pneumococcal bacteraemia had sickle 
cell disease (HbSS). 
 
Table S4. Distributions of sickle cell trait and leucocyte haemozoin pigment among cases who 
were bacteraemic with different pathogen subgroups. 
 
 Bacterial pathogen isolated in blood cultures Fisher 
Exposure 
Streptococcus 
pneumoniae 
non-Typhi 
Salmonella 
Other Gram 
positive 
Other Gram 
negative 
Exact P 
value 
HbAA 92 52 18 84  
HbAS 9 4 4 8 0.49 
no pigment 98 41 21 82  
leucocyte 
haemozoin pigment 13 20 1 15 0.003 
 
The results of haemoglobin electrophoresis were unavailable from 7 bacteraemic cases and a further 14 
cases were excluded because they had sickle cell disease (HbSS). The table tests the hypotheses that (i) 
the association between sickle cell trait and bacteraemia varies by bacterial pathogen and (ii) the 
association between leucocyte haemozoin pigment and bacteraemia varies by pathogen. This is found 
to be true for leucocyte haemozoin pigment but not for sickle cell phenotype. 
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Table S5. Population size, numbers of paediatric admissions to Kilifi District Hospital with 
malaria or bacteraemia and incidence of malaria and bacteraemia 1999-2007. 
 
Except where marked (e.g. *Incidence / 1000 / year; # 95% confidence intervals) numbers in cells are 
counts of children admitted to hospital with bacteraemia of the categories indicated. One child with H. 
influenzae type b bacteraemia also had pneumococcal bacteraemia (the child was excluded from this 
analysis). Fifty children had 2 bacterial isolates and two children had 3 isolates from the same blood 
culture. Two of the children with multiple cultures had 2 "Other Gram negative organisms"; 28 
children had at least one Gram positive and one Gram negative isolate from the same blood culture. 
† includes Enterococcus species, Streptococcus groups B, C, F and G and Staphylococcus 
saprophyticcus. 
 ¶ includes Campylobacter, Enterobacter, Neisseria, Proteus, Salmonella Typhi and Shigella species. 
Year 1999 2000 2001 2002 2003 2004 2005 2006 2007 
          
Population <14 years 76,210 81,033 86,161 91,614 97,991 102,280 106,046 108,948 111,054 
          
Malaria slide positive admissions  
Total 2,170 1,898 1,802 1,617 1,799 1,145 770 623 383 
Incidence* 28.47 23.42 20.91 17.65 18.36 11.19 7.26 5.72 3.45 
Lower CI# 27.29 22.38 19.96 16.80 17.52 10.56 6.76 5.28 3.11 
Upper CI# 29.70 24.50 21.90 18.53 19.23 11.86 7.79 6.19 3.81 
          
Bacteraemia positive admissions 
Any pathogenic bacteria 197 200 197 181 231 200 161 158 161 
Incidence* 2.59 2.47 2.29 1.98 2.36 1.96 1.52 1.45 1.45 
Lower CI# 2.24 2.14 1.98 1.70 2.06 1.69 1.29 1.23 1.23 
Upper CI# 2.97 2.83 2.63 2.29 2.68 2.25 1.77 1.69 1.69 
Gram positive organisms          
S pneumoniae 40 64 63 57 84 73 51 39 51 
S aureus 18 8 23 15 26 24 18 25 24 
Group A Streptococci 11 7 14 13 14 12 7 7 5 
Other Gram positive 
organisms† 
9 12 19 13 13 12 25 21 13 
Any Gram positive 
organisms 
77 91 118 97 135 115 100 92 91 
Gram negative organisms          
H influenzae non-type b 6 7 2 3 5 3 4 3 1 
non-Typhi Salmonella 52 32 25 37 34 13 10 8 13 
E coli 22 20 14 14 20 15 8 18 21 
Acinetobacter species 16 17 17 14 22 26 15 20 18 
Pseudomonas species 8 13 6 7 6 9 11 9 3 
Klebsiella species 4 8 9 3 1 9 5 0 3 
Other Gram negative 
organisms¶ 
17 16 14 10 11 15 14 11 11 
Any Gram negative 
organism 
123 110 85 88 97 89 67 69 70 
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Figure S1. Effect of individual adjustment for markers of malaria on the unadjusted odds ratio 
for the association between sickle cell trait (HbAS) and bacteraemia in children in the matched 
case-control study. 
 
 
Each line shows a different conditional logistic regression model of the matched case-control data after 
adjustment for HbSS, HIV and mid-upper arm circumference. Testing the hypothesis that malaria is on 
the causal pathway of the protective effect of HbAS on bacteraemia, the figure illustrates the effect of 
individual adjustment for malaria, using all the available markers in turn, on the odds ratio for HbAS. 
As accurate ascertainment of clinical malaria is difficult, especially among febrile IBD patients who 
may have taken anti-malarial drugs prior to presentation to hospital, we decided to control for malaria 
at the population level rather than the individual level in the longitudinal case-control study. 
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Figure S2. Bacteraemia incidence each year among children aged <14 years admitted to Kilifi 
District Hospital from within the KHDSS study area against yearly prevalence of P. falciparum 
parasitaemia from 1999-2007. 
 
 
 
Episodes of H. influenzae type b bacteraemia are not included in the estimates of bacteraemia 
incidence. These data were used in a Poisson regression analysis to estimate the bacteraemia Incidence 
Rate Ratio for malaria parasitaemia. 
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